- 专利标题: Nucleic acid nanoparticles for analyte detection
-
申请号: US16110545申请日: 2018-08-23
-
公开(公告)号: US10900067B2公开(公告)日: 2021-01-26
- 发明人: Aleksei Aksimentiev , Kirill A. Afonin , Meni Wanunu
- 申请人: The Board of Trustees of the University of Illinois , University of North Carolina-Charlotte , Northeastern University
- 申请人地址: US IL Urbana; US NC Charlotte; US MA Boston
- 专利权人: The Board of Trustees of the University of Illinois,University of North Carolina-Charlotte,Northeastern University
- 当前专利权人: The Board of Trustees of the University of Illinois,University of North Carolina-Charlotte,Northeastern University
- 当前专利权人地址: US IL Urbana; US NC Charlotte; US MA Boston
- 代理机构: Leydig, Voit & Mayer, Ltd.
- 主分类号: C12Q1/6869
- IPC分类号: C12Q1/6869 ; C12Q1/6809 ; C12N15/65 ; C12N15/113 ; C12N15/11 ; B82Y5/00 ; B82Y15/00
摘要:
Provided is a highly multiplex approach to disease condition diagnostics that combines nanopore sensing and nucleic acid nanoparticle (NANP) design and synthesis to detect multiple biomarkers to diagnose diseases. The system works by taking a sample containing biomarkers that is mixed with a plurality of nucleic acid nanoparticle (NANP) populations, with each population designed and synthesized to be able to detect a particular biomarker. Upon incubation, the mixture is used with nanopore measurements, with recordings of the ionic current through the nanopore. The ionic current recordings are analyzed, which determines the presence and/or concentration of biomarkers in the sample.
公开/授权文献
- US20190062814A1 NUCLEIC ACID NANOPARTICLES FOR ANALYTE DETECTION 公开/授权日:2019-02-28
信息查询